JAM
CPRX

Jupiter Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Jupiter Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.79M Sell
274,419
-115,949
-30% -$2.76M 0.04% 319
2025
Q4 		$9.11M Sell
390,368
-10,723
-3% -$239K 0.07% 226
2025
Q3 		$7.9M Sell
401,091
-116,575
-23% -$2.4M 0.07% 240
2025
Q2 		$11.2M Buy
517,666
+29,079
+6% +$686K 0.09% 222
2025
Q1 		$11.8M Buy
488,587
+6,600
+1% +$149K 0.11% 208
2024
Q4 		$10.1M Sell
481,987
-217,957
-31% -$4.68M 0.1% 226
2024
Q3 		$13.9M Sell
699,944
-41,731
-6% -$774K 0.12% 197
2024
Q2 		$11.5M Sell
741,675
-67,685
-8% -$1.05M 0.11% 194
2024
Q1 		$12.9M Sell
809,360
-34,571
-4% -$521K 0.12% 196
2023
Q4 		$14.2M Sell
843,931
-53,115
-6% -$726K 0.14% 181
2023
Q3 		$10.5M Buy
897,046
+350,184
+64% +$4.68M 0.12% 197
2023
Q2 		$7.34M Sell
546,862
-876,722
-62% -$12.6M 0.08% 243
2023
Q1 		$23.6M Buy
1,423,584
+1,376,339
+2,913% +$22.7M 0.33% 97
2022
Q4 		$878K Buy
47,245
+879
+2% +$13.5K 0.01% 376
2022
Q3 		$595K Buy
46,366
+15,679
+51% +$186K 0.01% 423
2022
Q2 		$215K Buy
+30,687
New +$225K ﹤0.01% 549

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jupiter Asset Management's CPRX Position: Q1 2026 in Review

Jupiter Asset Management reduced its Catalyst Pharmaceutical (CPRX) stake by 30% in Q1 2026, selling an estimated $2.76M and leaving 274,419 shares worth $6.79M. The position accounts for 0.04% of the portfolio, ranked #319.

Jupiter Asset Management first reported a position in CPRX in Q2 2022 and has held it in 16 quarters since. The position peaked at $23.6M in Q1 2023. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Jupiter Asset Management held 274,419 shares of Catalyst Pharmaceutical worth $6.79M as of Q1 2026.
  • Jupiter Asset Management sold 115,949 Catalyst Pharmaceutical shares in Q1 2026, an estimated $2.76M.
  • Catalyst Pharmaceutical made up 0.04% of Jupiter Asset Management's portfolio in Q1 2026, its #319 holding.
  • Jupiter Asset Management first reported a position in Catalyst Pharmaceutical in Q2 2022 and has held it in 16 quarters since.
  • Jupiter Asset Management's Catalyst Pharmaceutical position peaked at $23.6M in Q1 2023.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Jupiter Asset Management's 13F filing for Q1 2026, filed 12 May 2026.